osimertinib’s value in egfr-mutant nsclc
Published 6 years ago • 63 plays • Length 5:26Download video MP4
Download video MP3
Similar videos
-
4:39
defining osimertinib’s value in treating egfr nsclc
-
3:02
osimertinib in advanced egfr t790m-mutant nsclc
-
3:27
egfr-mutant nsclc: selecting patients for osimertinib
-
3:09
case 2: osimertinib in egfr-mutated lung cancer
-
2:21
osimertinib ipilimumab in egfr-mutated nsclc
-
1:57
dr. wakelee on benefits of osimertinib in egfr-mutant nsclc treatment
-
0:48
investigating osimertinib for brain activity in egfr-mutated lung cancer
-
4:04
treating with osimertinib in egfr-mutated nsclc
-
3:20
egfr mutated nsclc disease progression on osimertinib - 2022 program: targeted therapies forum
-
5:24
case 4: egfr mutation analysis post-osimertinib
-
3:30
osimertinib for uncommon egfr mutations in nsclc
-
0:58
adaura study demonstrates promising efficacy for osimertinib in egfr-mutant nsclc
-
1:53
resistance to osimertinib in egfr-mutated nsclc
-
2:50
sequencing with osimertinib in egfr-mutated nsclc
-
1:53
resistance to osimertinib in egfr-mutated nsclc
-
0:42
dr. fidler discusses osimertinib in egfr-mutated lung cancer
-
3:02
osimertinib in advanced egfr t790m-mutant nsclc
-
2:11
dr. low on osimertinib versus dacomitinib in egfr-mutant nsclc
-
3:59
osimertinib for egfr t790m resistance mutations in nsclc